These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Characteristics and management of ocular sarcoidosis. Takase H Immunol Med; 2022 Mar; 45(1):12-21. PubMed ID: 34214013 [TBL] [Abstract][Full Text] [Related]
9. ACQUIRED VITELLIFORM LESIONS THAT RESPOND TO IMMUNE SUPPRESSION IN A PATIENT WITH SARCOIDOSIS. Heymann HB; Jampol LM Retin Cases Brief Rep; 2020; 14(2):146-149. PubMed ID: 29068911 [TBL] [Abstract][Full Text] [Related]
10. Distinguishing Features of Ocular Sarcoidosis in an International Cohort of Uveitis Patients. Acharya NR; Browne EN; Rao N; Mochizuki M; Ophthalmology; 2018 Jan; 125(1):119-126. PubMed ID: 28823384 [TBL] [Abstract][Full Text] [Related]
16. Uveitis in sarcoidosis. Uyama M Int Ophthalmol Clin; 2002; 42(1):143-50. PubMed ID: 12189610 [TBL] [Abstract][Full Text] [Related]
17. [Sarcoidosis and uveitis : An update]. Garweg JG Ophthalmologe; 2017 Jun; 114(6):525-533. PubMed ID: 27904945 [TBL] [Abstract][Full Text] [Related]
18. [Sudden hearing loss and uveitis as a form of presentation of neurosarcoidosis]. García Berrocal JR; Trinidad A; Vargas JA; Hijós M; Ramón y Cajal S; Ramírez Camacho R Acta Otorrinolaringol Esp; 1998; 49(6):488-90. PubMed ID: 9830227 [TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis and uveitis. Jones NP Ophthalmol Clin North Am; 2002 Sep; 15(3):319-26, vi. PubMed ID: 12434480 [TBL] [Abstract][Full Text] [Related]